Primary Site >> Esophagus Cancer

Gene >> PROM1

  • 2012
  • 2013
  • 2014
  • 2016
  • 2017
  • 2018
Ref: Nucleostemin and TWIST as predictive markers for recurrence after neoadjuvant chemotherapy for esophageal carcinoma.
PMID: 22050045
Ref: The usefulness of three-dimensional cell culture in induction of cancer stem cells from esophageal squamous cell carcinoma cell lines.
PMID: 23602898
Ref: Physiological beta-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma.
PMID: 24073846
Ref: Anti-CSC effects in human esophageal squamous cell carcinomas and Eca109/9706 cells induced by nanoliposomal quercetin alone or combined with CD 133 antiserum.
PMID: 25374189
Ref: Prognostic value of cancer stem cell marker CD133 expression in esophageal carcinoma: A meta-analysis.
PMID: 26870362
Ref: Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy.
PMID: 27748881
Ref: MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF.
PMID: 28288140
Ref: Nano Let7b sensitization of eliminating esophageal cancer stemlike cells is dependent on blockade of Wnt activation of symmetric division.
PMID: 28902370
Ref: IGF2 induces CD133 expression in esophageal cancer cells to promote cancer stemness.
PMID: 29604392